SEC Form 4 · accession 0001493152-26-029030
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis H Titterton Jr.
Director
Period of report
Jun 16, 2026
Accepted (ET)
Jun 17, 2026 · 11:21 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 16, 2026 | P | 2,836 | $2.64 | A | 972,170 | D |
Table II — derivative securities
No Table II lines on this filing.